<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Henrietta Scholtz — HTBAA Fall 2026 :: 2026a-henrietta-scholtz</title><link>https://pages.htgaa.org/2026b/henrietta-scholtz/index.html</link><description>About me</description><generator>Hugo</generator><language>en</language><atom:link href="https://pages.htgaa.org/2026b/henrietta-scholtz/index.xml" rel="self" type="application/rss+xml"/><item><title>Week 1 HW: Final Project Ideas</title><link>https://pages.htgaa.org/2026b/henrietta-scholtz/week-01-hw-project-ideas/index.html</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://pages.htgaa.org/2026b/henrietta-scholtz/week-01-hw-project-ideas/index.html</guid><description>What I want to make and why A non-refrigerated, dry-stable oxytocin formulation for postpartum hemorrhage, obstetric emergencies, and PTSD in low-resource settings. This project began as a research narrative driven by curiosity rather than a predetermined application. In the course of that work, a novel engineered protein with no direct natural counterpart emerged as a candidate stabilizing carrier, and it occurred to me that something like this, if it works, could matter in exactly the settings where cold chain access is most limited. The protein has never been made or tested in this context, which means the application is genuinely open.</description></item><item><title>Final Project</title><link>https://pages.htgaa.org/2026b/henrietta-scholtz/final-project/index.html</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://pages.htgaa.org/2026b/henrietta-scholtz/final-project/index.html</guid><description/></item></channel></rss>